Clinical Trials List
2020-02-01 - 2025-12-10
Phase III
Recruiting5
Terminated3
ICD-10C34.2
Malignant neoplasm of middle lobe, bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.4
Malignant neoplasm of middle lobe, bronchus or lung
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 蕭慈慧 無
- 趙恒勝 無
- Yung-Hung Luo 無
- Chia-I Shen 無
- Chao-Hua Chiu 無
- Hsu-ching Huang 無
- YEN-HAN TSENG 無
- Chi-Lu Chiang 無
- Heng-Sheng Chao 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖斌志 Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shih-Hong Li Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- 黃宗楨 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
- 枋岳甫 Division of Infectious Disease
- 邱立忠 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Po-Lan Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Tao Chen Division of Thoracic Medicine
- Ching-Shan Luo Division of Thoracic Medicine
- kang-Yun LEE Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tzu-Tao Chen Division of Thoracic Medicine
- KUAN-LI WU 無
- Chih-Jen Yang 無
- 李玫萱 無
- Ying-Ming Tsai Tsai 無
- Inn-Wen Chong 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14-28 participants
-
Global
500 participants
